Treatment for Scars - What is the best?

What is the best treatment for scars? Many, including leading physicians and specialists, would say that silicone gel is a highly effective treatment. A recent publication titled “International Clinical Recommendations on Scar Management was developed by a group of scar specialists. This panel of world-reknowned physicians recommends the use of silicone as first-line therapy for the treatment and prevention of abnormal scars, including a wide variety of scar types.1 Silicone gel is thought to work as a treatment for scars by creating the ideal environment for the scar to mature: it forms a protective and breathable barrier that binds to the top layer of the skin and allows hydration of the skin.

Silicone is the clinical gold standard for the treatment of scars and abnormal scar prevention. For those looking to purchase a silicone treatment for scars: Kelo-cote® is a patented, 100% silicone gel for the management and prevention of abnormal scars in the form of hypertrophic scars and keloids.

A favorite of doctors and patients since 1998, Kelo-cote® has been clinically proven to reduce the redness, hardness, elevation, itch and pain associated with scars.2 It has also demonstrated efficacy in preventing abnormal scars .3,4,5 It can make otherwise normal scars look better as well.4

The Siliclear Complex™ is the foundation of Kelo-cote® scar treatment products; it refers to the patented combination of silicone ingredients including long chain polymer liquid, volatile, and solid silicones. This precise formula, combined with a highly specialized manufacturing process, transforms these ingredients into our highly effective scar treatment gels and spray.

Kelo-cote® helps to reduce scars and restore confidence. Regardless of the origin of the scar, Kelo-cote® has proven results, as evidenced by clinical studies and satisfied healthcare professionals and customers from around the world. Kelo-cote® is the most studied topical scar product, with more than 2,000 patients participating in a variety of published clinical studies.

References

1. Mustoe TA et al. Plast Reconstr Surg 2002;110:560-571.

2. Sepehrmanesh M. Komp Dermatologie 2006;1:30-32.

3. Signorini M, Clementoni MT. Aesth Plast Surg 2007;31: 183-187.

4. Spencer J. Journal of Drugs in Dermatology 2010; 7:856-858.

5. Radwanski H. Rev. Bras. Cir. Plást. 428 2010; 25(3): 428-33.